MRI lesion profiles in sporadic Creutzfeldt-Jakob disease

Neurology

Volumn 72, Issue 23, 2009, Pages 1994-2001

  Meissner, B ^a   Kallenberg, K ^a   Sanchez Juan, P ^b   Collie, D ^c   Summers, D M ^c   Almonti, S ^d   Collins, S J ^e   Smith, P ^f   Cras, P ^g   Jansen, G H ^h   Brandel, J P ⁱ   Coulthart, M B ^h   Roberts, H ^e   Van Everbroeck, B ^g   Galanaud, D ⁱ   Mellina, V ^d   Will, R G ^c   Zerr, I ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f Victoria House   (Australia)

^g UNIVERSITY OF ANTWERP   (Belgium)

^h PUBLIC HEALTH AGENCY OF CANADA   (Canada)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL GANGLION; BRAIN CORTEX; CEREBELLUM; CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; FLUID ATTENUATED INVERSION RECOVERY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO; THALAMUS;

EID: 67649479370     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a96e5d     Document Type: Article

References (23)

1. Gertz HJ, Henkes H, Cervos NJ. Creutzfeldt-Jakob disease: correlation of MRI and neuropathologic findings. Neurology 1988;38:1481-1482.
2. Schröter A, Zerr I, Henkel K, Tschampa HJ, Finkenstaedt M, Poser S. Magnetic resonance imaging (MRI) in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000;57:1751-1757.
3. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. Am J Neuroradiol 2005;26: 1551-1562.
4. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443-449.
5. Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, et al. Clinical findings and diagnostic tests in the MV-2 subtype of sporadic CJD. Brain 2006;129:2288-2296.
6. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46: 224-233.
7. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-778.
8. Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006;129:2278-2287.
9. Zerr I, Schulz-Schaeffer WJ, Giese A, et al. Current clinical diagnosis in CJD: identification of uncommon variants. Ann Neurol 2000;48:323-329.
10. Castellani RJ, Colucci M, Xie Z, et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt- Jakob disease. Neurology 2004;63:436-442.
11. Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006;67:637-643.
12. Krasnianski A, Meissner B, Schulz-Schaeffer W, et al. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2006;63:876-880.
13. Hamaguchi T, Kitamoto T, Sato T, et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology 2005;64:643-648.
14. Fukushima R, Shiga Y, Nakamura M, Fujimori J, Kitamato T, Yoshida Y. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrP type 2 in Japan. J Neurol Neurosurg Psychiatry 2004;75:485-487.
15. Meissner B, Westner I, Kallenberg K, et al. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005;65:1544- 1550.
16. Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease: accuracy and reliability of periodic sharp wave complexes in Creutzfeldt- Jakob disease. Ann Neurol 2004;56:702-708.
17. Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006;67:637-643.
18. Tschampa HJ, Kallenberg K, Kretzschmar HA, et al. Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2007;28:1114-1118.
19. Collie DA, Summers DM, Sellar RJ, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiol 2003;24:1560-1569.
20. Hamaguchi T, Kitamoto T, Sato T, et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology 2005;64:643-648.
21. Pauri F, Amabile G, Fattapposta F, Pierallini A, Bianco F. Sporadic Creutzfeldt-Jakob disease without dementia at onset: clinical features, laboratory tests and sequential diffusion MRI (in an autopsy proven case). Neurol Sci 2004; 25:234-237.
22. Meissner B, Kallenberg K, Sanchez-Juan P, et al. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2008;29:1519 -1524.
23. Kallenberg K, Schulz-Schaeffer WJ, Jastrow U, et al. Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. AJNR Am J Neuroradiol 2006;27:1459- 1462.